Lorenzo Pierre

Corporate ControllerMillendo Therapeutics, Inc. (TPST) · full profile →Form 4 · filed Jun 29, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 25, 2021Grant(A)5353

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 25, 2021Grant(A)5K5K
Jun 25, 2021Grant(A)49K49K
Jun 25, 2021Grant(A)1K1K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-21-022781) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.